arrow
J

Javier Fernández

hospital clinic
H指数:61
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper

全球关于急性-on-慢性肝衰竭患者重症监护管理的共识:APASL ACLF北京立场文件

2026-07-300
PRE
Effectiveness of cardiac Holter monitoring for more than four weeks for the detection of occult atrial fibrillation in embolic stroke of undetermined source

对不明原因栓塞性卒中患者进行超过四周的心脏动态心电图监测以检测隐匿性心房颤动的有效性

2026-07-010
PRE
Multidrug-resistant colonization in decompensated cirrhosis outside the ICU predicts infection and poor outcomes

多药耐药定植在非ICU的失代偿期肝硬化患者中预测感染和不良结局

2025-12-080
OAAI
Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy

突破接受免疫治疗晚期HCC患者进入重症监护的障碍

2025-08-120
OAAI
Low-Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double-Blind Randomised Placebo-Controlled Trial

低剂量氢化可的松在肝硬化合并脓毒症休克患者中的应用:一项双盲随机安慰剂对照试验

2025-08-040
OAAI
Assessment of low-dose Follitropin Delta administration on ovarian response in Patients with Polycystic Ovary Syndrome undergoing Intrauterine Insemination (IUI): a pilot prospective cohort dose-response study

低剂量Follitropin Delta给药对行宫腔内人工授精(IUI)的Polycystic Ovary Syndrome患者卵巢反应的评估:一项前瞻性队列剂量-反应关系研究

2025-06-010
OAAI
Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

白蛋白重新编程b细胞转录景观并改善失代偿期肝硬化患者的中性粒细胞抗菌功能

2024-11-010
OAAI
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosis
2024-08-152
PRE
A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis
2024-06-271
OAAI
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
2024-02-275
OAAI
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections-Results from the ICA Global Study (EABCIR-Global Study)
2023-12-014
PRE
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
2023-10-063
PRE